RAD50 and clear cell renal carcinoma: Clinical Proteomic Tumour Analysis Consortium (CPTAC) data also revealed upregulation of Rad50 in ovarian, breast, colon cancers and Clear cell renal cell carcinoma (Figure S1C).26